Maravai Lifesciences Holdings (MRVI) Tax Provisions (2020 - 2026)
Maravai Lifesciences Holdings' (MRVI) quarterly Tax Provisions came in at -$151000.0 in Q1 2026, down 193.21% year-on-year from $162000.0 in Q1 2025, and down 2616.67% quarter-over-quarter from $6000.0 in Q4 2025.
Maravai Lifesciences Holdings (MRVI) Tax Provisions (2020 - 2026) Analysis & Trends
Maravai Lifesciences Holdings' Tax Provisions history runs 7 years deep, the most recent figure standing at -$151000.0 for Q1 2026.
- On a quarterly basis, Tax Provisions fell 193.21% year-over-year to -$151000.0 in Q1 2026; TTM through Mar 2026 was -$4.5 million, a 129.81% decrease from a year earlier, with the FY2025 full-year figure at -$4.2 million, down 126.45% from the prior year.
- Tax Provisions eased to -$151000.0 in Q1 2026 per MRVI's latest filing, from $6000.0 in the prior quarter.
- Across five years, Tax Provisions topped out at $766.2 million in Q4 2023 and bottomed at -$5.5 million in Q3 2023.
- The 5-year median for Tax Provisions is $6000.0 (2025), against an average of $47.7 million.
- Across the five-year window, Tax Provisions surged 8970.3% in 2023 and tumbled 193.21% in 2026, its largest moves.
- Year by year, Tax Provisions stood at $8.4 million in 2022, then jumped by 8970.3% to $766.2 million in 2023, then slumped by 100.0% to -$7000.0 in 2024, then soared by 185.71% to $6000.0 in 2025, then sank by 2616.67% to -$151000.0 in 2026.
- Per Business Quant, the three latest MRVI Tax Provisions figures stand at -$151000.0 (Q1 2026), $6000.0 (Q4 2025), and -$92000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 125,146.46 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 31.86 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 188,883.60 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 221.50 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 179.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Maravai Lifesciences Holdings | 1.03 Bn | 1.02 Bn | 33.70 Mn | -151,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -151,000.00 |
| Dec 31, 2025 | 6,000.00 |
| Sep 30, 2025 | -92,000.00 |
| Jun 30, 2025 | -4.29 Mn |
| Mar 31, 2025 | 162,000.00 |
| Dec 31, 2024 | -7,000.00 |
| Sep 30, 2024 | 311,000.00 |
| Jun 30, 2024 | -2.44 Mn |
| Mar 31, 2024 | 271,000.00 |
| Dec 31, 2023 | 766.17 Mn |
| Sep 30, 2023 | -5.46 Mn |
| Jun 30, 2023 | -1.42 Mn |
| Mar 31, 2023 | -3.18 Mn |
| Dec 31, 2022 | 8.45 Mn |
| Sep 30, 2022 | 14.11 Mn |
| Jun 30, 2022 | 18.27 Mn |
| Mar 31, 2022 | 19.98 Mn |
| Dec 31, 2021 | 17.58 Mn |
| Sep 30, 2021 | 18.84 Mn |
| Jun 30, 2021 | 11.39 Mn |